Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NYU Grossman School of Medicine
AddedFeb 15, 2024
UpdatedJun 18, 2026
NYU Grossman School of Medicine

NYU Grossman School of Medicine

NYU Grossman School of Medicine: A renowned medical institution under NYU Langone Health, NYC.

HQ
New York City, NY, US
Founded
1841
Overview
Compare
Fundraising
Employees
Website

NYU Grossman School of Medicine, founded in 1841, is a prestigious medical school under New York University and part of NYU Langone Health. Located in New York City, it offers a range of educational programs including MD degrees, graduate medical education, and continuing medical education. The institution is dedicated to pushing the boundaries of medical education and research to improve patient lives and drive innovation in science and medicine.

NYU Grossman School of Medicine has made significant strides in medical research and education, contributing to advancements in healthcare. It is affiliated with notable figures such as Kenneth Langone, an investment banker and financial backer of The Home Depot, after whom NYU Langone Health is named. The school continues to be a leader in the medical field, fostering a vibrant community committed to excellence in healthcare.

NYU Grossman School of Medicine - Quick Facts

When was NYU Grossman School of Medicine founded?

NYU Grossman School of Medicine was founded in 1841.

Where is NYU Grossman School of Medicine's headquarters located?

NYU Grossman School of Medicine's headquarters is located in New York City, NY, US.

How much has NYU Grossman School of Medicine raised to-date?

As of May 18, 2023, NYU Grossman School of Medicine has raised a total of $5.7M (USD).

How many employees does NYU Grossman School of Medicine have?

NYU Grossman School of Medicine has 10,000 employees as of Feb 4, 2024.

NYU Grossman School of Medicine - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • HealthTech
Geographic Exposure
  • United States
Customer
  • Consumers
  • Education
Main Product
  • Medical Education
NAICS
  • 610000Educational Services
  • 611000Educational Services
SIC
  • 8200Educational Services
  • 8290Schools And Educational Services, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 611300Colleges, Universities, and Professional Schools
  • 611310Colleges, Universities, and Professional Schools
  • 620000Health Care and Social Assistance
SIC
  • 8220Colleges, Universities, Professional Schools, And Junior Colleges
  • 8221Colleges, Universities, And Professional Schools
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified